Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, announced a licensing agreement with Gilead Sciences, Inc. to help the company leverage the power of multi-omics data in the discovery of life-changing therapeutics across multiple indications. The agreement includes a software license to Genedata Profiler, a domain-specific, state-of-art data integration and analytics platform, and access to consulting resources to support the adoption and integration of the solution within the company’s infrastructure.
“At Gilead, we work every day to discover innovative therapeutics for people with life-threatening diseases,” said Li Li, Executive Director, Research Data Sciences at Gilead. “Utilizing Genedata Profiler will enhance our capabilities for integration and analysis of large-scale multi-modal datasets as we continue to accelerate research for the discovery of transformative medicines.”
CIO INFLUENCE: Nextira Selected by Ansys Technology Partner Program to Support Customers Implementing Ansys Gateway Powered by AWS
As a comprehensive, end-to-end computational solution, Genedata Profiler enables biopharmaceutical organizations to conduct data-rich discovery and translational research and make more informed decisions, ultimately supporting the development of more effective, targeted treatments. It empowers data scientists to decipher complex patterns associated with a specific disease from Next Generation Sequencing (NGS) and other high-dimensional data, facilitating target identification and evaluation and biomarker research for a range of therapeutic indications.
The main benefits of Genedata Profiler include:
- A centralized data storage place to enable self-service access to a large variety of multi-omics data from past and ongoing experiments,
- Configurable automated workflows to streamline processing, integration, publishing, and analysis of a large amount of high-dimensional data,
- Advanced, yet intuitive analytical and visualization methods to help derive novel scientific insights,
- Efficient data-sharing tools with fine-grained access control to data to ensure seamless, yet secure collaboration across and beyond organizational units.
CIO INFLUENCE: CIO Influence Interview with Pete Lilley, Vice President and GM at Instaclustr
Beyond software, Genedata provides scientific domain expertise and 26 years of experience in supporting the biopharma industry in increasing the productivity and quality of their research output through digital transformation.
“We are excited to have signed Gilead Sciences to our rapidly growing customer list for our Genedata Profiler platform,” said Othmar Pfannes, Ph.D., CEO of Genedata. “Genedata Profiler democratizes access to R&D data and includes fit-for-purpose analytics, while automating highly complex data operations, all key requirements for enabling biopharmaceutical organizations to generate precision medicines as efficiently as possible.”
CIO INFLUENCE: JFrog Software Supply Chain Platform Delivers 393% ROI According to Total Economic Impact Study
[To share your insights with us, please write to sghosh@martechseries.com]
